Prevention and Early Detection

All Items

• Perspectives on artificial intelligence-generated chronic disease risk predictions in early breast cancer: an international survey among radiation oncologists

  Frederik Voigt Carstensen, Belinda Bøgh Irankunda, Eva Batista, Desiree van den Bongard, Tanja Spanic, Sofie A.M. Gernaat, Helena Verkooijen, Maja Vestmø Maraldo

  553-556

• Diagnostic pathways for lung cancer patients in Denmark: General practice events, first referral and stage at diagnosis

  Dorte Ejg Jarbøl, Peter Haastrup, Sanne Rasmussen, Gitte Bruun Lauridsen, Kirubakaran Balasubramaniam, Linda Juel Ahrenfeldt, Jesper Lykkegaard, Lisa Maria Sele Sætre

  525-534

• Baseline results from the Norwegian radiology-led lung cancer screening pilot

  Albin Mahovkic, Kirill Neumann, Trond-Eirik Strand, Oluf Dimitri Røe, Haseem Ashraf

  59-65

• Body composition changes in women with early breast cancer after adjuvant treatment: a systematic review

  Valdemar Mendez, Simone Diedrichsen Marstrand , August Nielsen, Trine Lund-Jacobsen, Caroline Kistorp, Peter Schwarz, Kristian Buch-Larsen

  1640-1647

• Urban-rural residence location and cancer-specific mortality among colorectal, lung and ovarian cancer patients: a nationwide retrospective cohort study from Lithuania

  Rūta Everatt, Birutė Brasiūnienė, Ieva Vincerževskienė, Birutė Intaitė, Saulius Cicėnas , Ingrida Lisauskienė

  1554-1558

• Improved therapies, incomplete data: late toxicity after modern classical Hodgkin Lymphoma radiotherapy

  Daniel Molin

  1540-1543

• Pulmonary nodules in Denmark: occurrence, resource use, and risk of lung cancer and death

  Cecilia Hvitfeldt Fuglsang, Ina Trolle Andersen, Frederik Pagh Bredahl Kristensen, Henriette Engberg, Morten Borg, Ole Hilberg, Torben Riis Rasmussen

  1497-1505

• How do health literacy and chronic disease influence the diagnostic evaluation of patients with lung cancer symptoms?

  Lisa Maria Sele Sætre, Kirubakaran Balasubramaniam, Sonja Wehberg, Christian Borbjerg Laursen, Jens Søndergaard, Dorte Ejg Jarbøl

  1455-1464

• Development and evaluation of a lymph node invasion risk prediction model in intermediate- and high-risk prostate cancer patients

  Håkon Ramberg, Manuela Zucknick, Francesco Barletta, Petter Davik, Åsmund Nybøen, Lars Magne Eri, Sivanthe Sivanesan, Knut Håkon Hole, Tord Hompland, Stian Ole Prestbakk, Giorgio Gandaglia, Tone Frost Bathen, Alberto Briganti, Viktor Berge, Kristin Austild Tasken

  1446-1454

• POT1 genetic testing in melanoma-prone families in Sweden: germline variant prevalence and tumor spectrum in identified carriers

  Konstantinos Papadakis, Francesca Portelli, Karina Schultz, Hedvig Olsson Sterky, Ismini Vassilaki, Jan Lapins, Michael R. Sargen, Sofia Obolenski, David J. Adams, Muyi Yang, Veronica Höiom, Hildur Helgadottir

  1102-1108
• 

  Thirty years of population-based breast cancer screening in Iceland: a comparison of quality indicators and tumour characteristics between women aged 40–49 and 50–69 years

  Alfheidur Haraldsdottir, Helgi Birgisson , Agust I. Agustsson, Laufey Tryggvadottir

  1061-1070

• Telemedicine follow-up for pre-malignant and malignant glottic lesions: a randomised controlled trial study protocol comparing care close to home versus standard of care

  Nathalie F. van Rhee, Rosanne C. Schoonbeek, Inge Wegner, Karin M. Vermeulen, Robert C. Maat, Dirk A. Dietz de Loos, György B. Halmos, Boudewijn E.C. Plaat

  1035-1040

• Lung cancer screening in Finland: a prospective randomized trial

  Viktor Wichmann, Sanna Iivanainen, Lauri Mattila, Veli-Pekka Kokkonen, Airi Jartti, Antti Kurtti, Riitta Kaarteenaho, Heidi Andersen, Antti Jekunen, Tuula Vasankari, Jussi Koivunen

  769-774

• Comparative study of lung cancer care and survival outcomes across the Nordic countries

  Ghida Khalife, Juho Waris, Uffe Bødtger, Johan Isaksson, Kirill Neumann, Hrönn Harðardóttir, Heidi Andersén, Antti Jekunen, Maria Lovén, Tuula Vasankari, Susanna Nurmi-Rantala, Paulus Torkki

  734-741

• A systematic review and meta-analysis of lung cancer risk prediction models

  Ghida Khalife, Matilda Nilsson, Lotta Peltola, Juho Waris, Antti Jekunen, Riikka-Leena Leskelä, Heidi Andersén, Mikko Nuutinen , Eija Heikkilä, Susanna Nurmi-Rantala, Paulus Torkki

  661-671

• The risk of myelodysplastic syndrome and acute myeloid leukemia by metformin use and type 2 diabetes status – a Danish nation-wide cohort study

  Emelie C. Rotbain, Klaus Rostgaard, Katja Kaastrup, Stine Ulrik Mikkelsen, Henrik Hjalgrim, Kirsten Grønbæk

  623-629

• Pre-treatment tumour PET metrics and clinical outcomes of anal cancer in patients living with and without HIV

  Michael Pennock, N. Patrik Brodin, Christian Velten, Megi Gjini, Nitin Ohri, Chandan Guha, Shalom Kalnicki, Wolfgang A. Tome, Madhur K. Garg, Rafi Kabarriti

  564-573

• Cardiotoxicity in patients with metastatic melanoma treated with BRAF/MEK inhibitors: a real-world analysis of incidence, risk factors, and reversibility

  Jonas K. Oddershede, Ida K. Meklenborg, Lars Bastholt, Louise M. Guldbrandt, Henrik Schmidt, Rasmus B. Friis

  507-515

• Multi-dimensional interpretable deep learning-radiomics based on intra-tumoral and spatial habitat for preoperative prediction of thymic epithelial tumours risk categorisation

  Yuhua Yang, Jia Cheng, Can Cui, Huijie Huang, Meiling Cheng, Jiayi Wang, Minjing Zuo

  391-405

• Fine needle aspiration cytology including the analysis of human papilloma virus (HPV) DNA enhances the diagnostic workup of solitary cystic neck lesions in a population with a high incidence of HPV positive oropharyngeal cancer

  Evelina Jörtsö, Linda Marklund, Martin Harper Hysek, Anders Näsman, Lalle Hammarstedt-Nordenvall, Mathias von Beckerath, Tina Dalianis, Rusana Bark

  276-283

• Circulating tumor DNA for surveillance in high-risk melanoma patients: a study protocol

  Magnús P.B. Obinah, Sarah A. Al-Halafi, Karin Dreisig, Tim S. Poulsen, Christoffer Johansen, Thomas Litman, Stig E. Bojesen, Estrid Høgdall, Annette H. Chakera, Lisbet R. Hölmich

  229-233

• Relapse detection in the Danish surveillance program of patients with clinical stage I seminoma: a nationwide study

  Niklas B. Lindahl, Jakob Lauritsen, Thomas Wagner, Gedske Daugaard, Mikkel Bandak

  191-199

• Lynch syndrome screening in colorectal and endometrial cancers in Iceland

  Katla R. Kluvers, Thordur Tryggvason, Vigdis Stefansdottir, Jon G. Jonasson, Petur Snaebjornsson, Sigurdis Haraldsdottir

  188-190

• Adherence to guidelines for incidental pulmonary nodules: insights from a Nordic survey

  Kirill Neumann, Janna Berg , Haseem Ashraf , Johan Isaksson , Aija Knuuttila, Morten H. Borg, Torben R. Rasmussen

  22-26

• Proportion and characteristics of screen-detected and non-screen-detected colo­rectal cancers in Germany

  Michel Hornschuch, Sarina Schwarz, Ulrike Haug

  924-931

• The risk of venous thromboembolism in adult patients with diffuse glioma: a nationwide population-based study

  Frederik R. Hovman, Frantz R. Poulsen, Steinbjørn Hansen, Rikke H. Dahlrot

  887-892

• A pilot study of AI-assisted reading of prostate MRI in Organized Prostate Cancer Testing

  Erik Thimansson, Sophia Zackrisson, Fredrik Jäderling, Max Alterbeck , Thomas Jiborn , Anders Bjartell , Jonas Wallström

  816-821

• Age-specific differences in breast cancer treatment between screen-detected and non-screen-detected breast cancers in women aged 40–74 years at diagnosis in Sweden 2008–2017

  Håkan Jonsson, Anne Andersson, Zheng Mao, Lennarth Nyström

  552-556

• Agent orange exposure and prostate cancer risk in the million veteran program

  Meghana S. Pagadala, Asona J. Lui, Allison Y. Zhong, Julie A. Lynch, Roshan Karunamuni, Kyung Min Lee, Anna Plym, Brent S. Rose, Hannah K. Carter, Adam S. Kibel, Scott L. DuVall, J. Michael Gaziano, Matthew S. Panizzon, Richard L. Hauger, Tyler M. Seibert

  373-378

• Area-based disparities in non-small-cell lung cancer survival

  Nelly-Maria Paakkola, Antti Jekunen, Eero Sihvo, Mikael Johansson, Heidi Andersén

  146-153